108 related articles for article (PubMed ID: 3373482)
1. Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor.
Hibert MF; Gittos MW; Middlemiss DN; Mir AK; Fozard JR
J Med Chem; 1988 Jun; 31(6):1087-93. PubMed ID: 3373482
[TBL] [Abstract][Full Text] [Related]
2. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
3. Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro.
Van den Hooff P; Galvan M
Br J Pharmacol; 1992 Aug; 106(4):893-9. PubMed ID: 1393288
[TBL] [Abstract][Full Text] [Related]
4. MDL 72832: a potent and stereoselective ligand at central and peripheral 5-HT1A receptors.
Mir AK; Hibert M; Tricklebank MD; Middlemiss DN; Kidd EJ; Fozard JR
Eur J Pharmacol; 1988 Apr; 149(1-2):107-20. PubMed ID: 2840295
[TBL] [Abstract][Full Text] [Related]
5. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
6. Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse.
Laporte AM; Lima L; Gozlan H; Hamon M
Eur J Pharmacol; 1994 Dec; 271(2-3):505-14. PubMed ID: 7705451
[TBL] [Abstract][Full Text] [Related]
7. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
[TBL] [Abstract][Full Text] [Related]
8. Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635.
Testa R; Guarneri L; Poggesi E; Angelico P; Velasco C; Ibba M; Cilia A; Motta G; Riva C; Leonardi A
J Pharmacol Exp Ther; 1999 Sep; 290(3):1258-69. PubMed ID: 10454502
[TBL] [Abstract][Full Text] [Related]
9. Derivatives of (R)- and (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: synthesis and interactions with 5-HT1A receptors.
Höök BB; Cortizo L; Johansson AM; Westlind-Danielsson A; Mohell N; Hacksell U
J Med Chem; 1996 Sep; 39(20):4036-43. PubMed ID: 8831769
[TBL] [Abstract][Full Text] [Related]
10. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
Bioorg Med Chem Lett; 2016 Aug; 26(16):4052-6. PubMed ID: 27396505
[TBL] [Abstract][Full Text] [Related]
12. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
[TBL] [Abstract][Full Text] [Related]
13. Analogues of the 5-HT1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity.
Raghupathi RK; Rydelek-Fitzgerald L; Teitler M; Glennon RA
J Med Chem; 1991 Aug; 34(8):2633-8. PubMed ID: 1652026
[TBL] [Abstract][Full Text] [Related]
14. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
15. Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C; Kleven M
J Med Chem; 1999 May; 42(9):1648-60. PubMed ID: 10229633
[TBL] [Abstract][Full Text] [Related]
16. Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites.
López-Rodríguez ML; Morcillo MJ; Benhamú B; Rosado ML
J Comput Aided Mol Des; 1997 Nov; 11(6):589-99. PubMed ID: 9491351
[TBL] [Abstract][Full Text] [Related]
17. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
[TBL] [Abstract][Full Text] [Related]
18. Conformational flexibility of serotonin1A receptor ligands from crystallographic data. Updated model of the receptor pharmacophore.
Chilmonczyk Z; Szelejewska-Wozniakowska A; Cybulski J; Cybulski M; Koziol AE; Gdaniec M
Arch Pharm (Weinheim); 1997 May; 330(5):146-60. PubMed ID: 9237427
[TBL] [Abstract][Full Text] [Related]
19. 8-[4-[2-(1,2,3,4-Tetrahydroisoquinolinyl]butyl-8-azaspiro[4.5]decane-7,9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone.
Mokrosz JL; Dereń-Wesołek A; Tatarczyńska E; Duszyńska B; Bojarski AJ; Mokrosz MJ; Chojnacka-Wójcik E
J Med Chem; 1996 Mar; 39(5):1125-9. PubMed ID: 8676348
[TBL] [Abstract][Full Text] [Related]
20. (R)- and (S)-5,6,7,8-tetrahydro-1-hydroxy-N,N-dipropyl-9H-benzocyclohepten- 8-ylamine. Stereoselective interactions with 5-HT1A receptors in the brain.
Liu Y; Mellin C; Björk L; Svensson B; Csöregh I; Helander A; Kenne L; Andén NE; Hacksell U
J Med Chem; 1989 Oct; 32(10):2311-8. PubMed ID: 2795604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
